IGFBP-3 proteolysis by plasmin, thrombin, serum: Heparin binding, IGF binding, and structure of fragments

被引:58
作者
Booth, BA
Boes, M
Bar, RS
机构
[1] UNIV IOWA, VET ADM MED CTR, DEPT INTERNAL MED, IOWA CITY, IA 52246 USA
[2] UNIV IOWA, VET ADM MED CTR, DEPT DIABET, IOWA CITY, IA 52246 USA
[3] UNIV IOWA, VET ADM MED CTR, ENDOCRINOL RES CTR, IOWA CITY, IA 52246 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 1996年 / 271卷 / 03期
关键词
endothelium; binding protein degradation; insulin-like growth factor; insulin-like growth factor binding protein-3;
D O I
10.1152/ajpendo.1996.271.3.E465
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IGFBP-3 proteolysis by plasmin, thrombin, serum: heparin binding, IGF binding, and structure of fragments. Am. J. Physiol. 271 (Endocrinol. Metab. 34): E465-E470, 1996.-Insulin-like growth factor binding protein (IGFBP)-3 was exposed to plasmin, thrombin, and pregnancy serum, substances normally present at the endothelial surface in enriched concentrations. The NH2-termini of the proteolytic fragments were sequenced, and their ability to bind insulin-like growth factor (IGF) and heparin was assessed by ligand blotting. Plasmin generated at least five fragments, three beginning at the NH2-terminus of IGFBP-3 and two with NH2-termini corresponding to middle portions of IGFBP-3. The dominant fragment bound both IGF and heparin while NH2-terminal fragments bound only IGF. Thrombin generated three and serum five easily identified fragments; the dominant fragments, beginning at midportions of IGFBP-3, retained IGF and heparin affinity, whereas the remaining fragments had differential affinities for IGF and heparin. We suggest that such fragments, when generated at the endothelial surface, have the potential to alter regional vascular concentrations of IGF and thus influence both IGF and endothelial function.
引用
收藏
页码:E465 / E470
页数:6
相关论文
共 20 条
[1]   GLYCOSAMINOGLYCANS INHIBIT DEGRADATION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-5 [J].
ARAI, T ;
ARAI, A ;
BUSBY, WH ;
CLEMMONS, DR .
ENDOCRINOLOGY, 1994, 135 (06) :2358-2363
[2]  
ARAI T, 1994, J BIOL CHEM, V269, P20388
[3]  
BACH LA, 1995, DIABETES REV, V3, P38
[4]   INCREASED PROTEOLYSIS OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3 (IGFBP-3) IN NONINSULIN-DEPENDENT DIABETES-MELLITUS SERUM, WITH ELEVATION OF A 29-KILODALTON (KDA) GLYCOSYLATED IGFBP-3 FRAGMENT CONTAINED IN THE APPROXIMATELY 130-KDA TO 150-KDA TERNARY COMPLEX [J].
BANG, P ;
BRISMAR, K ;
ROSENFELD, RG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (05) :1119-1127
[5]   IN-VIVO PROTEOLYSIS OF SERUM INSULIN-LIKE GROWTH-FACTOR (IGF) BINDING PROTEIN-3 RESULTS IN INCREASED AVAILABILITY OF IGF TO TARGET-CELLS [J].
BLAT, C ;
VILLAUDY, J ;
BINOUX, M .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05) :2286-2290
[6]   INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEIN (IGFBP)4 ACCOUNTS FOR THE CONNECTIVE-TISSUE DISTRIBUTION OF ENDOTHELIAL-CELL IGFBPS PERFUSED THROUGH THE ISOLATED HEART [J].
BOES, M ;
BOOTH, BA ;
SANDRA, A ;
DAKE, BL ;
BERGOLD, A ;
BAR, RS .
ENDOCRINOLOGY, 1992, 131 (01) :327-330
[7]  
BOOTH BA, 1995, GROWTH REGULAT, V5, P1
[8]   INVOLVEMENT OF THE PLASMIN SYSTEM IN DISSOCIATION OF THE INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN COMPLEX [J].
CAMPBELL, PG ;
NOVAK, JF ;
YANOSICK, TB ;
MCMASTER, JH .
ENDOCRINOLOGY, 1992, 130 (03) :1401-1412
[9]   PROTEOLYSIS OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-5 BY PREGNANCY SERUM AND AMNIOTIC-FLUID [J].
CLAUSSEN, M ;
ZAPF, J ;
BRAULKE, T .
ENDOCRINOLOGY, 1994, 134 (04) :1964-1966
[10]   ENDOGENOUS CATHEPSIN D-MEDIATED HYDROLYSIS OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEINS IN CULTURED HUMAN PROSTATIC-CARCINOMA CELLS [J].
CONOVER, CA ;
PERRY, JE ;
TINDALL, DJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (03) :987-993